This site is intended for healthcare professionals

Boehringer acquires NBE Therapeutics and with it NBE 002 in studies for triple negative breast cancer

Read time: 1 mins
Last updated:12th Dec 2020
Published:12th Dec 2020
Type: industry
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest